RYTM logo

Rhythm Pharmaceuticals (RYTM) Selling, general & administrative expenses

annual SGA:

$144.30M+$26.77M(+22.78%)
December 31, 2024

Summary

  • As of today (June 19, 2025), RYTM annual SGA is $144.30 million, with the most recent change of +$26.77 million (+22.78%) on December 31, 2024.
  • During the last 3 years, RYTM annual SGA has risen by +$75.82 million (+110.71%).
  • RYTM annual SGA is now at all-time high.

Performance

RYTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRYTMincome statement metrics

quarterly SGA:

$39.09M+$957.00K(+2.51%)
March 31, 2025

Summary

  • As of today (June 19, 2025), RYTM quarterly SGA is $39.09 million, with the most recent change of +$957.00 thousand (+2.51%) on March 31, 2025.
  • Over the past year, RYTM quarterly SGA has increased by +$4.71 million (+13.68%).
  • RYTM quarterly SGA is now at all-time high.

Performance

RYTM quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRYTMincome statement metrics

TTM SGA:

-$4.54B-$168.73M(-3.86%)
March 31, 2025

Summary

  • As of today (June 19, 2025), RYTM TTM SGA is -$4.54 billion, with the most recent change of -$168.73 million (-3.86%) on March 31, 2025.
  • Over the past year, RYTM TTM SGA has dropped by -$4.67 billion (-3667.46%).
  • RYTM TTM SGA is now -5832.03% below its all-time high of -$76.54 million.

Performance

RYTM TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRYTMincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

RYTM Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+22.8%+13.7%-3667.5%
3 y3 years+110.7%+82.2%-6120.6%
5 y5 years+294.8%+205.5%-10000.0%

RYTM Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+110.7%at high+82.2%-121.7%at low
5 y5-yearat high+294.8%at high+338.1%-268.1%at low
alltimeall timeat high+4113.3%at high+3880.3%-5832.0%at low

RYTM Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Mar 2025
-
$39.09M(+2.5%)
$149.01M(+3.3%)
Dec 2024
$144.30M(+22.8%)
$38.13M(+7.8%)
$144.30M(+4.2%)
Sep 2024
-
$35.38M(-2.9%)
$138.55M(+3.7%)
Jun 2024
-
$36.41M(+5.9%)
$133.65M(+5.0%)
Mar 2024
-
$34.38M(+6.2%)
$127.28M(+8.3%)
Dec 2023
$117.53M(+27.7%)
$32.37M(+6.2%)
$117.53M(+5.4%)
Sep 2023
-
$30.48M(+1.4%)
$111.47M(+8.3%)
Jun 2023
-
$30.05M(+22.0%)
$102.94M(+8.1%)
Mar 2023
-
$24.63M(-6.4%)
$95.22M(+3.5%)
Dec 2022
$92.03M(+34.4%)
$26.32M(+20.0%)
$92.03M(+6.1%)
Sep 2022
-
$21.94M(-1.7%)
$86.71M(+5.4%)
Jun 2022
-
$22.33M(+4.1%)
$82.28M(+9.1%)
Mar 2022
-
$21.45M(+2.2%)
$75.42M(+10.1%)
Dec 2021
$68.49M(+48.5%)
$21.00M(+19.9%)
$68.49M(+13.0%)
Sep 2021
-
$17.51M(+13.2%)
$60.61M(+11.4%)
Jun 2021
-
$15.46M(+6.5%)
$54.39M(+13.7%)
Mar 2021
-
$14.52M(+10.7%)
$47.85M(+3.7%)
Dec 2020
$46.13M
$13.12M(+16.2%)
$46.13M(+8.7%)
DateAnnualQuarterlyTTM
Sep 2020
-
$11.29M(+26.5%)
$42.42M(+1.8%)
Jun 2020
-
$8.92M(-30.3%)
$41.67M(+0.2%)
Mar 2020
-
$12.80M(+35.9%)
$41.59M(+13.8%)
Dec 2019
$36.55M(+30.2%)
$9.41M(-10.6%)
$36.55M(+2.9%)
Sep 2019
-
$10.54M(+19.2%)
$35.52M(+6.0%)
Jun 2019
-
$8.84M(+13.9%)
$33.53M(+7.7%)
Mar 2019
-
$7.76M(-7.5%)
$31.12M(+10.8%)
Dec 2018
$28.08M(+195.0%)
$8.39M(-1.8%)
$28.08M(+16.9%)
Sep 2018
-
$8.54M(+32.7%)
$24.02M(+35.0%)
Jun 2018
-
$6.44M(+36.5%)
$17.80M(+39.9%)
Mar 2018
-
$4.71M(+8.9%)
$12.72M(+33.6%)
Dec 2017
$9.52M(+50.8%)
$4.33M(+87.0%)
$9.52M(+20.0%)
Sep 2017
-
$2.31M(+70.6%)
$7.93M(+20.2%)
Jun 2017
-
$1.36M(-10.5%)
$6.60M(+25.9%)
Mar 2017
-
$1.52M(-44.8%)
$5.24M(+40.7%)
Dec 2016
$6.31M(+84.3%)
$2.74M(+179.4%)
$3.73M(+279.4%)
Sep 2016
-
$982.00K
$982.00K
Dec 2015
$3.42M
-
-

FAQ

  • What is Rhythm Pharmaceuticals annual SGA?
  • What is the all time high annual SGA for Rhythm Pharmaceuticals?
  • What is Rhythm Pharmaceuticals annual SGA year-on-year change?
  • What is Rhythm Pharmaceuticals quarterly SGA?
  • What is the all time high quarterly SGA for Rhythm Pharmaceuticals?
  • What is Rhythm Pharmaceuticals quarterly SGA year-on-year change?
  • What is Rhythm Pharmaceuticals TTM SGA?
  • What is the all time high TTM SGA for Rhythm Pharmaceuticals?
  • What is Rhythm Pharmaceuticals TTM SGA year-on-year change?

What is Rhythm Pharmaceuticals annual SGA?

The current annual SGA of RYTM is $144.30M

What is the all time high annual SGA for Rhythm Pharmaceuticals?

Rhythm Pharmaceuticals all-time high annual SGA is $144.30M

What is Rhythm Pharmaceuticals annual SGA year-on-year change?

Over the past year, RYTM annual SGA has changed by +$26.77M (+22.78%)

What is Rhythm Pharmaceuticals quarterly SGA?

The current quarterly SGA of RYTM is $39.09M

What is the all time high quarterly SGA for Rhythm Pharmaceuticals?

Rhythm Pharmaceuticals all-time high quarterly SGA is $39.09M

What is Rhythm Pharmaceuticals quarterly SGA year-on-year change?

Over the past year, RYTM quarterly SGA has changed by +$4.71M (+13.68%)

What is Rhythm Pharmaceuticals TTM SGA?

The current TTM SGA of RYTM is -$4.54B

What is the all time high TTM SGA for Rhythm Pharmaceuticals?

Rhythm Pharmaceuticals all-time high TTM SGA is -$76.54M

What is Rhythm Pharmaceuticals TTM SGA year-on-year change?

Over the past year, RYTM TTM SGA has changed by -$4.67B (-3667.46%)
On this page